MENU
AARD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Aardvark Therapeutics (AARD) Ownership - Who owns Aardvark Therapeutics?

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
89.01M
P/E Ratio
N/A
Total Cash
91.2M
Projected Growth
N/A
Total Debt
336K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
4.18
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
AARD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details